טוען...
Discovery of Genetic Variants of the Kinases That Activate Tenofovir in a Compartment-specific Manner
Tenofovir (TFV) is used in combination with other antiretroviral drugs for human immunodeficiency virus (HIV) treatment and prevention. TFV requires two phosphorylation steps to become pharmacologically active; however, the kinases that activate TFV in cells and tissues susceptible to HIV infection...
שמור ב:
| הוצא לאור ב: | EBioMedicine |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4588390/ https://ncbi.nlm.nih.gov/pubmed/26501112 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2015.07.008 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|